Sarana Meditama Metropolitan Cash Flow Conversion Efficiency

Latest as of June 2026: 0.011x

Sarana Meditama Metropolitan cash flow conversion efficiency. Based on the latest financial reports, Sarana Meditama Metropolitan (SAME) has a cash flow conversion efficiency ratio of 0.011x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp44.49 Billion ≈ $2.61 Million USD) by net assets (Rp4.20 Trillion ≈ $246.10 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Sarana Meditama Metropolitan (2011–2025)

Cash flow conversion efficiency of Sarana Meditama Metropolitan from 2011 to 2025. This chart illustrates how Sarana Meditama Metropolitan's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Sarana Meditama Metropolitan (SAME) stock price for real-time trading data and today's change.

Sarana Meditama Metropolitan Cash Flow Conversion Ratio Explained

Sarana Meditama Metropolitan cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Sarana Meditama Metropolitan Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sarana Meditama Metropolitan ranked by their cash flow conversion efficiency. Also see SAME market cap overview for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
AstroNova Inc
NASDAQ:ALOT
0.039x
RF Capital Group Inc
TO:RCG
0.017x
Egis Technology
TWO:6462
0.002x
Pss Co Ltd
TW:6914
0.236x
Nam Kim Steel JSC
VN:NKG
0.062x
Dateline Resources Ltd
AU:DTR
-0.116x
Copper Fox Metals Inc.
V:CUU
0.003x
Bioteque
TWO:4107
0.036x

Annual Cash Flow Conversion Efficiency for Sarana Meditama Metropolitan (2011–2025)

The table below shows the annual cash flow conversion efficiency of Sarana Meditama Metropolitan from 2011 to 2025. Review how much free cash does Sarana Meditama Metropolitan generate to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Rp4.17 Trillion
≈ $244.10 Million
Rp357.02 Billion
≈ $20.92 Million
0.086x +34.64%
2024-12-31 Rp4.14 Trillion
≈ $242.49 Million
Rp263.42 Billion
≈ $15.44 Million
0.064x +67.33%
2023-12-31 Rp3.98 Trillion
≈ $233.42 Million
Rp151.55 Billion
≈ $8.88 Million
0.038x +1481.24%
2022-12-31 Rp3.98 Trillion
≈ $233.39 Million
Rp9.58 Billion
≈ $561.51K
0.002x -95.80%
2021-12-31 Rp4.43 Trillion
≈ $259.67 Million
Rp253.74 Billion
≈ $14.87 Million
0.057x +244.24%
2020-12-31 Rp545.82 Billion
≈ $31.98 Million
Rp-21.67 Billion
≈ $-1.27 Million
-0.040x -120.60%
2019-12-31 Rp977.50 Billion
≈ $57.28 Million
Rp188.40 Billion
≈ $11.04 Million
0.193x +716.24%
2018-12-31 Rp1.33 Trillion
≈ $77.70 Million
Rp31.31 Billion
≈ $1.83 Million
0.024x -62.85%
2017-12-31 Rp1.04 Trillion
≈ $61.07 Million
Rp66.26 Billion
≈ $3.88 Million
0.064x -56.32%
2016-12-31 Rp850.97 Billion
≈ $49.86 Million
Rp123.85 Billion
≈ $7.26 Million
0.146x +10.60%
2015-12-31 Rp741.18 Billion
≈ $43.43 Million
Rp97.53 Billion
≈ $5.71 Million
0.132x -77.37%
2014-12-31 Rp191.08 Billion
≈ $11.20 Million
Rp111.12 Billion
≈ $6.51 Million
0.582x +3.41%
2013-12-31 Rp133.01 Billion
≈ $7.79 Million
Rp74.80 Billion
≈ $4.38 Million
0.562x -80.36%
2012-12-31 Rp19.22 Billion
≈ $1.13 Million
Rp55.04 Billion
≈ $3.23 Million
2.863x +137.81%
2011-12-31 Rp-4.05 Billion
≈ $-237.07K
Rp30.64 Billion
≈ $1.80 Million
-7.573x --

About Sarana Meditama Metropolitan

JK:SAME Indonesia Medical Care Facilities
Market Cap
$227.31 Million
Rp3.88 Trillion IDR
Market Cap Rank
#15807 Global
#193 in Indonesia
Share Price
Rp226.00
Change (1 day)
-1.74%
52-Week Range
Rp226.00 - Rp428.00
All Time High
Rp755.00
About

PT Sarana Meditama Metropolitan Tbk engages in the hospital management of EMC Hospital Pulomas in Pulomas, East Jakarta. The company operates specialty centers. It also is involved in trading of medical equipment; healthcare pharmacy; real estate; and agriculture. The company was founded in 1984 and is based in Jakarta, Indonesia. PT Sarana Meditama Metropolitan Tbk is a subsidiary of PT Elang Ma… Read more